Roche Gears Up To Launch Actemra; Lines Up More Clinical Research In India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Unperturbed by the spate of patent litigations, Swiss drug maker Roche is planning to bring into India Actemra (tocilizumab), its biological therapy indicated for the treatment of rheumatoid arthritis in adults and children